快速分解的口腔膜含有尼载荷的体
Ali A Amer1, Yasir Karkar1, Lewis Bingle2
1School of Pharmacy and Pharmaceutical Sciences, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK.
Molecules (Basel, Switzerland)
|September 27, 2025
概括
这项研究在快速溶解的口腔膜中开发了含尼的尼索姆,用于有针对性的口腔输送. 这种新的平台增强了尼的稳定性和治疗口腔感染的疗效.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
背景情况:
- 尼辛是一种来自乳球菌乳酸菌的兰氏菌,具有广泛的抗微生物活性,可以对抗包括MRSA在内的格兰阳性病原体.
- 目前的抗微生物药物如尼的输送方法可能缺乏稳定性和膜应用的向输送.
- 开发先进的药物输送系统对于提高基于的抗微生物药物的治疗疗效至关重要.
研究的目的:
- 开发和描述一种新的纳米药物输送平台,用于尼,使用纳米体集成到快速溶解的口腔膜中.
- 为了评估尼载体的物理化学性质,稳定性和抗菌疗效,在口服膜剂型中.
- 探索该系统在口腔局部抗菌疗法的潜力.
主要方法:
- 使用微流体混合与Span 40,Span 60和胆固醇,制备了尼载荷的体.
- 使用聚乙烯醇 (PVA) 和聚乙烯糖醇400 (PEG400) 将尼奥索姆悬浮物纳入基于聚合物的口腔膜中.
- 描述包括囊泡大小,多分散性,封装效率,FTIR,DSC,TGA,SEM,机械性质,分解时间和体外抗菌试验.
主要成果:
- 微流体合成产生了均的体 (100-200 nm),具有高封装效率和更好的尼稳定性.
- 口腔膜表现出快速分解 (<30秒),良好的机械性能和均的药物分布.
- 配制的尼保留了其生物活性,显示出有效的抑制区域对抗细菌.
结论:
- 开发的含尼的阴带性口腔膜为向口腔药物输送提供了稳定有效的平台.
- 这种新的系统增强了尼的治疗潜力,用于局部治疗口腔感染,牙斑和牙周疾病.
- 微流体和口腔膜的整合提供了一个有希望的非侵入性策略,用于基药物的粘膜输送.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
In Vitro Drug Dissolution: Alternative Methods
198
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
198


